Related Experiment Videos
Chemotherapy plus RA233 in the treatment of oat cell lung cancer
A Lipton1, H A Harvey, B Walker
1Department of Medicine, Milton S. Hershey Medical Center, Hershey, PA 17033.
American Journal of Clinical Oncology
|June 1, 1989
Abstract:
One hundred and one patients with oat (small) cell lung cancer have been treated with CAVE [Cytoxan, Adriamycin, Vincristine, and etoposide (VP-16)] chemotherapy +/- RA233 (a platelet-inhibiting agent). There was no difference in disease-free interval, pattern of relapse, or survival between groups.